|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it’s a cool place to work
|
|
Jan 10
|
Drugs group Sanofi makes Olympic jump in rebrand bid
|
|
Jan 9
|
Press Release: Brian Foard appointed Head of Specialty Care Global Business Unit, member of Sanofi Executive Committee
|
|
Jan 2
|
MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why
|
|
Jan 2
|
China Approves AstraZeneca-Sanofi's Respiratory Syncytial Virus Drug To Prevent Infection In Infants
|
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
|
Dec 22
|
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
|
|
Dec 22
|
Pharma Stock Roundup: FDA Nod to AZN's Eplontersen, CRL to MRK's Cough Candidate
|
|
Dec 21
|
Sanofi scraps a top ADC prospect after study setback
|
|
Dec 21
|
Press Release: Sanofi announces end of program evaluating tusamitamab ravtansine after a 2L NSCLC Phase 3 trial did not meet a primary endpoint
|
|
Dec 19
|
13 Most Promising Healthcare Stocks According to Analysts
|
|
Dec 18
|
Sanofi: Information concerning the total number of voting rights and shares - November 2023
|
|
Dec 18
|
UPDATE 2-US antitrust enforcers release final version of new merger guidelines
|
|
Dec 18
|
Sanofi: The Current Price Makes No Sense
|
|
Dec 10
|
25 Most Valuable European Companies Heading into 2024
|
|
Dec 8
|
Kymera (KYMR) Rises as Dosing Begins in AD Study on KT-474
|
|
Dec 7
|
UPDATE 2-US urges makers of infant RSV shots to meet winter demand
|
|
Dec 7
|
Sanofi (SNY) Posts Upbeat Long-Term Outlook, Enhances R&D Focus
|